Geovax Labs Inc (GOVX) Receives Notice of Allowance for Hepatitis B Vaccine Patent streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent
GeoVax, Inc.April 1, 2021 GMT
Therapeutic Vaccine Would Address Medical Need of Over 250 Million Worldwide
Atlanta, GA - ( NewMediaWire ) - April 01, 2021 - GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent Application No. 16/305,305 entitled “Composition and Methods of Generating an Immune Response to Hepatitis B Virus.”